| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.787 | 71.198 | 82.579 | 68.091 | 53.458 | 69.875 | 2.638 | 19 | 11.072 | 14.465 |
| Total Income - EUR | 19.717 | 71.237 | 88.481 | 68.219 | 53.626 | 71.281 | 2.777 | 19 | 22.192 | 14.484 |
| Total Expenses - EUR | 25.482 | 62.066 | 87.835 | 70.677 | 55.034 | 63.759 | 5.352 | 10.070 | 21.502 | 17.654 |
| Gross Profit/Loss - EUR | -5.765 | 9.171 | 646 | -2.458 | -1.407 | 7.522 | -2.575 | -10.052 | 691 | -3.170 |
| Net Profit/Loss - EUR | -6.363 | 8.087 | -243 | -3.144 | -1.944 | 6.809 | -2.658 | -10.052 | 469 | -3.315 |
| Employees | 1 | 2 | 4 | 4 | 4 | 4 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - S T K Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 699 | 460 | 229 | 45 | 486 | 389 | 337 | 288 | 982 | 642 |
| Current Assets | 11.533 | 17.229 | 6.719 | 9.148 | 12.997 | 13.918 | 10.838 | 8.789 | 10.998 | 7.035 |
| Inventories | 7.495 | 16.381 | 4.318 | 8.303 | 11.975 | 12.298 | 10.151 | 8.388 | 3.851 | 5.762 |
| Receivables | 3.058 | 332 | 1.703 | 410 | 561 | 1.088 | 5 | 393 | 5.384 | 793 |
| Cash | 980 | 515 | 698 | 435 | 461 | 533 | 682 | 8 | 1.762 | 481 |
| Shareholders Funds | -7.148 | 745 | -190 | -3.331 | -5.210 | 1.698 | -998 | -11.045 | -10.543 | -13.798 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 19.380 | 16.944 | 7.139 | 12.525 | 18.693 | 12.619 | 12.174 | 20.121 | 22.523 | 21.476 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5210 - 5210" | |||||||||
| CAEN Financial Year |
5210
|
|||||||||
Comments - S T K Pharma Srl